7 found
Order:
See also
Lisa Diependaele
University of Ghent
  1.  22
    Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies.Oliver Feeney, Julian Cockbain, Michael Morrison, Lisa Diependaele, Kristof Van Assche & Sigrid Sterckx - 2018 - American Journal of Bioethics 18 (12):36-48.
    In 2012, a new and promising gene manipulation technique, CRISPR-Cas9, was announced that seems likely to be a foundational technique in health care and agriculture. However, patents have been granted. As with other technological developments, there are concerns of social justice regarding inequalities in access. Given the technologies’ “foundational” nature and societal impact, it is vital for such concerns to be translated into workable recommendations for policymakers and legislators. Colin Farrelly has proposed a moral justification for the use of patents (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   11 citations  
  2.  24
    Climate Change and Individual Responsibility. Agency, Moral Disengagement and the Motivational Gap.Wouter Peeters, Andries De Smet, Lisa Diependaele, Sigrid Sterckx, R. H. McNeal & A. D. Smet - 2015 - Palgrave MacMillan.
    If climate change represents a severe threat to humankind, why then is response to it characterized by inaction at all levels? The authors argue there are two complementary explanations for the lack of motivation. First, our moral judgment system appears to be unable to identify climate change as an important moral problem and there are pervasive doubts about the agency of individuals. This explanation, however, is incomplete: Individual emitters can effectively be held morally responsible for their luxury emissions. Second, doubts (...)
    Direct download  
     
    Export citation  
     
    Bookmark   6 citations  
  3.  39
    Moral Disengagement and the Motivational Gap in Climate Change.Wouter Peeters, Lisa Diependaele & Sigrid Sterckx - 2019 - Ethical Theory and Moral Practice 22 (2):425-447.
    Although climate change jeopardizes the fundamental human rights of current as well as future people, current actions and ambitions to tackle it are inadequate. There are two prominent explanations for this motivational gap in the climate ethics literature. The first maintains that our conventional moral judgement system is not well equipped to identify a complex problem such as climate change as an important moral problem. The second explanation refers to people’s reluctance to change their behaviour and the temptation to shirk (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  4.  8
    Similar or the Same? Why Biosimilars Are Not the Solution.Lisa Diependaele, Julian Cockbain & Sigrid Sterckx - 2018 - Journal of Law, Medicine and Ethics 46 (3):776-790.
    Advancements in the field of biotechnology have accelerated the development of drugs that are manufactured from cultures of living cells, commonly referred to as “biologics.” Due to the complexity of the production process, generic biologics are unlikely to be chemically identical to the reference product, and accordingly are referred to as “biosimilars.”Encouraging the development of biosimilars has been presented as the key solution to decrease prices and increase access to biologics, but the development and use of biosimilars continues to raise (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  5.  21
    Response to Open Peer Commentaries on “Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies”.Sigrid Sterckx, Kristof Van Assche, Lisa Diependaele, Michael Morrison, Julian Cockbain & Oliver Feeney - 2019 - American Journal of Bioethics 19 (1):W10-W13.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  6.  10
    Recensies - Dorota Mokrosińska _. _Rethinking Political Obligation: Moral Principles, Communal Ties, Citizenship. Hampshire: Palgrave Macmillan, 2012. 221 Pp. [REVIEW]Lisa Diependaele & Andries De Smet - 2014 - Algemeen Nederlands Tijdschrift voor Wijsbegeerte 106 (1):91-93.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  7.  3
    Mandating Data Exclusivity for Pharmaceuticals Through International Agreements: A Fair Idea?Lisa Diependaele & Sigrid Sterckx - 2018 - In David Boonin, Katrina L. Sifferd, Tyler K. Fagan, Valerie Gray Hardcastle, Michael Huemer, Daniel Wodak, Derk Pereboom, Stephen J. Morse, Sarah Tyson, Mark Zelcer, Garrett VanPelt, Devin Casey, Philip E. Devine, David K. Chan, Maarten Boudry, Christopher Freiman, Hrishikesh Joshi, Shelley Wilcox, Jason Brennan, Eric Wiland, Ryan Muldoon, Mark Alfano, Philip Robichaud, Kevin Timpe, David Livingstone Smith, Francis J. Beckwith, Dan Hooley, Russell Blackford, John Corvino, Corey McCall, Dan Demetriou, Ajume Wingo, Michael Shermer, Ole Martin Moen, Aksel Braanen Sterri, Teresa Blankmeyer Burke, Jeppe von Platz, John Thrasher, Mary Hawkesworth, William MacAskill, Daniel Halliday, Janine O’Flynn, Yoaav Isaacs, Jason Iuliano, Claire Pickard, Arvin M. Gouw, Tina Rulli, Justin Caouette, Allen Habib, Brian D. Earp, Andrew Vierra, Subrena E. Smith, Danielle M. Wenner, Lisa Diependaele, Sigrid Sterckx, G. Owen Schaefer, Markus K. Labude, Harisan Unais Nasir, Udo Schuklenk, Benjamin Zolf & Woolwine (eds.), The Palgrave Handbook of Philosophy and Public Policy. Springer Verlag. pp. 575-591.
    Data exclusivity is a temporary exclusive user right on the clinical data that need to be submitted to the regulatory authorities to prove that a new drug is safe and effective. For the pharmaceutical industry, data exclusivity is an important addition to the patent system, as data exclusivity will de facto delay the market entry of generic drugs until after the exclusive user rights on the clinical data have expired. In order to assess the normative legitimacy of the industry’s demand (...)
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark